Filing Details
- Accession Number:
- 0000711377-17-000046
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-15 08:23:30
- Reporting Period:
- 2017-11-13
- Accepted Time:
- 2017-11-15 08:23:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1168789 | L James Herbert | Neogen Corp 620 Lesher Place Lansing MI 48912 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-13 | 8,000 | $36.07 | 879,430 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-11-13 | 19,000 | $39.61 | 898,430 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-11-13 | 26,000 | $81.45 | 872,430 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock (Right to Buy) | Disposition | 2017-11-13 | 8,000 | $0.00 | 8,000 | $36.07 |
| Common Stock | common Stock (Right to Buy) | Disposition | 2017-11-13 | 19,000 | $0.00 | 19,000 | $39.61 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 321,425 | 2018-08-30 | No | 4 | M | Direct | |
| 302,425 | 2019-10-01 | No | 4 | M | Direct |
Footnotes
- Options were granted 8/30/2013, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
- Options were granted 10/1/2014, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
Billionaire Hedge Funds
